Mittie Doyle

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Christopher Sullivan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mittie Doyle:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Chief Medical Officer Common Stock 3,622 $14,850 $4.10 10 Dec 2025 Direct
Avalo Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 105,000 26 Feb 2026 Direct
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 79,456 07 Aug 2025 Direct
DICE Therapeutics, Inc. Director Stock Option (right to buy) 0 09 Aug 2023 Direct

Insider Reports Filed by Mittie Doyle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVTX Avalo Therapeutics, Inc. 26 Feb 2026 1 $0 4 Chief Medical Officer 02 Mar 2026, 16:23
AVTX Avalo Therapeutics, Inc. 10 Dec 2025 1 -$4,153 4 Chief Medical Officer 12 Dec 2025, 16:18
CGEM Cullinan Therapeutics, Inc. 07 Aug 2025 1 $0 4 Director 08 Aug 2025, 17:30
CGEM Cullinan Therapeutics, Inc. 07 Aug 2025 0 $0 3 Director 08 Aug 2025, 17:30
AVTX Avalo Therapeutics, Inc. 28 Jan 2025 1 $0 4 Chief Medical Officer 30 Jan 2025, 17:20
AVTX Avalo Therapeutics, Inc. 15 Jul 2024 1 $0 4 Chief Medical Officer 16 Jul 2024, 16:23
AVTX Avalo Therapeutics, Inc. 15 Jul 2024 0 $0 3 Chief Medical Officer 16 Jul 2024, 16:17
/report/000120919123045170-doyle-mittie-2023-08-09 DICE Therapeutics, Inc. 09 Aug 2023 1 $0 4 Director 09 Aug 2023, 16:21
/report/000120919122022056-doyle-mittie-2022-03-31 DICE Therapeutics, Inc. 31 Mar 2022 1 $0 4 Director 01 Apr 2022, 18:27
/report/000120919122022049-doyle-mittie-2022-03-24 DICE Therapeutics, Inc. 24 Mar 2022 0 $0 3 Director 01 Apr 2022, 18:12